SKI Market

A+| A| A-|

Indian Indices

Sensex

74,557.86 -51.12
( -0.07%)

Global Indices

Nasdaq

49,714.12 -67.45
(-0.14%)

Dow Jones

7,466.35 44.39
(0.60%)

Hang Seng

63,198.64 456.07
(0.73%)

Nikkei 225

10,300.99 35.67
(0.35%)

Forex

USD-INR

95.60 0.47
(0.49%)

EUR-INR

112.29 0.30
(0.26%)

GBP-INR

129.50 0.02
(0.02%)

JPY-INR

0.61 0.00
(0.19%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Astal Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

512600

INE307N01014

76.88845

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

34.81

340.89

EPS(TTM)

Face Value()

Div & Yield %

2.32

Back

EPL consolidated net profit rises 19.89% in the September 2025 quarter

Nov 11,2025

Net profit of EPL rose 19.89% to Rs 104.30 crore in the quarter ended September 2025 as against Rs 87.00 crore during the previous quarter ended September 2024. Sales rose 11.02% to Rs 1205.90 crore in the quarter ended September 2025 as against Rs 1086.20 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	1205.90	1086.20	11
OPM %	20.86	20.13	-
PBDT	235.30	203.60	16
PBT	140.90	118.40	19
NP	104.30	87.00	20

74,557.86 -51.12 ( -0.07%)

49,714.12 -67.45 (-0.14%)

7,466.35 44.39 (0.60%)

63,198.64 456.07 (0.73%)

10,300.99 35.67 (0.35%)

95.60 0.47 (0.49%)

112.29 0.30 (0.26%)

129.50 0.02 (0.02%)

0.61 0.00 (0.19%)